Search research articles
Contact Us
Filters
Showing results (331-340 of 340) with videos related to
Page
of 34
Sort By:
You have reached the last page of results.
This site can display upto 340 results.
The American Journal of Physiology
|
February 11, 1990
Characterization of the major form of cholecystokinin in human intestine: CCK-58
V E Eysselein, G A Eberlein, M Schaeffer, et al.
European Journal of Pharmacology
|
October 14, 1994
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors
D Grandt, F Feth, W Rascher, et al.
Hepatology (Baltimore, Md.)
|
March 1, 1984
(+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial
H Schomerus, K H Wiedmann, W Dölle, et al.
Pancreas
|
March 1, 1995
Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors
D Grandt, J Siewert, B Sieburg, et al.
Peptides
|
July 1, 1989
A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)
G A Eberlein, V E Eysselein, M Schaeffer, et al.
Inflammatory Bowel Diseases
|
January 4, 2013
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*
M Campieri, H Goebell, S Hanauer, et al.
Scandinavian Journal of Gastroenterology
|
January 1, 1979
A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis
H Goebell, R Ammann, C Herfarth, et al.
Gut
|
July 1, 1996
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study
R Löfberg, P Rutgeerts, H Malchow, et al.
Zeitschrift Fur Gastroenterologie
|
August 31, 2000
[The therapy of acute pancreatitis. General guidelines. Working group of the Society for Scientific-Medical Specialties]
M Rünzi, P Layer, M W Büchler, et al.
Zeitschrift Fur Gastroenterologie
|
February 24, 2001
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]
E F Stange, J Riemann, A von Herbay, et al.
Page
of 34
Search research articles
Search
Showing results (331-340 of 340) with videos related to
Sort By:
Page
of 34
You have reached the last page of results.
This site can display upto 340 results.
The American Journal of Physiology
|
February 11, 1990
Characterization of the major form of cholecystokinin in human intestine: CCK-58
V E Eysselein, G A Eberlein, M Schaeffer, et al.
European Journal of Pharmacology
|
October 14, 1994
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors
D Grandt, F Feth, W Rascher, et al.
Hepatology (Baltimore, Md.)
|
March 1, 1984
(+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial
H Schomerus, K H Wiedmann, W Dölle, et al.
Pancreas
|
March 1, 1995
Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors
D Grandt, J Siewert, B Sieburg, et al.
Peptides
|
July 1, 1989
A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)
G A Eberlein, V E Eysselein, M Schaeffer, et al.
Inflammatory Bowel Diseases
|
January 4, 2013
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*
M Campieri, H Goebell, S Hanauer, et al.
Scandinavian Journal of Gastroenterology
|
January 1, 1979
A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis
H Goebell, R Ammann, C Herfarth, et al.
Gut
|
July 1, 1996
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study
R Löfberg, P Rutgeerts, H Malchow, et al.
Zeitschrift Fur Gastroenterologie
|
August 31, 2000
[The therapy of acute pancreatitis. General guidelines. Working group of the Society for Scientific-Medical Specialties]
M Rünzi, P Layer, M W Büchler, et al.
Zeitschrift Fur Gastroenterologie
|
February 24, 2001
[Diagnosis and therapy of ulcerative colitis--results of an evidence-based consensus conference of the German Society of Digestive and Metabolic Diseases]
E F Stange, J Riemann, A von Herbay, et al.
Page
of 34